top of page

Publications

Mobilizing pharmacists to address the opioid crisis, a joint opinion of the ambulatory care and adult medicine practice and research networks for the American College of Clinical Pharmacy

J Am Coll Clin Pharm. 2020. DOI: 10.1002/jac5.1331

Coon SA, Hill LG, Hutchison RW, Arnold LM, Jarrett JB, Ottney AR, Oung AB, Painter NA, Smith MA, Stranges PM, Tran TH, McFee Winans AR, Bratberg JP. 

Read More

Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA

Addiction. 2021. DOI: 10.1111/add.15314

Hill LG, Loera LJ, Evoy KE, Torrez SB, Renfro ML, Zagorski CM, Perez JC, Jones SM, Reveles KR. 

Read More

Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19

Am J Health Syst Pharm. 2021. DOI: 10.1093/ajhp/zxab003

Peckham AM, Ball J, Colvard MD, Dadiomov D, Hill LG, Nichols SD, Tallian K, Ventricelli DJ, Tran TH. 

Read More

Considering the potential benefits of over-the-counter naloxone

Integr Pharm Res Pract. 2021. DOI: 10.2147/iprp.S244709

Evoy KE, Hill LG, Davis CS. 

Read More
bottom of page